Vice President, Head of Research @ (November 2020 - February 2022)
Vice President of Experimental Medicine @ Kintai Therapeutics (December 2019 - November 2020)
Head of Experimental Medicine @ Kintai Therapeutics (September 2019 - November 2020)
Director of Business Engagement College of MDS University of Birmingham @ (February 2018 - December 2019)
Reader in Translational Rheumatology @ (March 2017 - December 2019)
Clinician Scientist, Consultant in Rheumatology @ (February 2010 - December 2019)
Research Associate @ Dep. Immunobiology Kings College London (January 2007 - January 2010)
Francesca Barone Education
King's College London
Doctor of Philosophy (Ph.D.) (Medicine)
2008-2008
Sapienza Università di Roma
Specialization in Rheumatology (Medicine)
2007-2007
Sapienza Università di Roma
Doctor of Medicine (MD) (Medicine)
2001
Francesca Barone Skills
Research and Development (R&D)
Pre-clinical Studies
In Vivo
Immunotherapy
Global Perspective
Clinical Development
Oncology
Drug Development
Cancer Immunotherapy
Cell Biology
Clinical Research
Immunology
Molecular Biology
Cell Culture
Rheumatology
Cell
Life Sciences
Science
Research
Flow Cytometry
Italian
Inflammation
Francesca Barone Summary
Francesca Barone, based in United States, is currently a Chief Scientific Officer at Candel Therapeutics. Francesca Barone brings experience from previous roles at Marseille Immunology Biocluster, Candel Therapeutics and Kintai Therapeutics. Francesca Barone holds a 2008 - 2008 Doctor of Philosophy (Ph.D.) in Medicine @ King's College London. With a robust skill set that includes Research and Development (R&D), Pre-clinical Studies, In Vivo, Immunotherapy, Global Perspective and more. Francesca Barone has 2 emails and 5 mobile phone numbers on RocketReach.
Looking for a different Francesca Barone?
Find contact details for 700 million professionals.